unifypharma.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php | ||
Meta Tags
| Title | Unify |
| Description | Potent inhibitors of inflammatory and oxidative Developing novel solutions totarget neurodegenerative diseases.Unify will be led by some of the brightest scientific minds in the world with a proven record of creating and developing the world’s most successful drugs.Targeting some of the world’s |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 104.21.57.212 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
unifypharma.com Valuation
|
US$359,438
Last updated: 2022-11-08 10:08:16
unifypharma.com has Semrush global rank of 29,446,816. unifypharma.com has an estimated worth of US$ 359,438, based on its estimated Ads revenue. unifypharma.com receives approximately 41,474 unique visitors each day. Its web server is located in United States, with IP address 104.21.57.212. According to SiteAdvisor, unifypharma.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$359,438 |
| Daily Ads Revenue | US$332 |
| Monthly Ads Revenue | US$9,954 |
| Yearly Ads Revenue | US$119,444 |
| Daily Unique Visitors | 2,765 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| unifypharma.com. | A | 300 | IP: 104.21.57.212 |
| unifypharma.com. | A | 300 | IP: 172.67.167.6 |
| unifypharma.com. | AAAA | 300 | IPV6: 2606:4700:3034::ac43:a706 |
| unifypharma.com. | AAAA | 300 | IPV6: 2606:4700:3031::6815:39d4 |
| unifypharma.com. | NS | 86400 | NS Record: dell.ns.cloudflare.com. |
| unifypharma.com. | NS | 86400 | NS Record: lewis.ns.cloudflare.com. |
| unifypharma.com. | MX | 300 | MX Record: 5 alt1.aspmx.l.google.com. |
| unifypharma.com. | MX | 300 | MX Record: 5 alt2.aspmx.l.google.com. |
| unifypharma.com. | MX | 300 | MX Record: 10 alt3.aspmx.l.google.com. |
| unifypharma.com. | MX | 300 | MX Record: 10 alt4.aspmx.l.google.com. |
| unifypharma.com. | MX | 300 | MX Record: 15 uwi5nmbkagp3cjpynsxjvazgi2spxi6g5zr2xmprkbw6xgvdxlba.mx-verification.google.com. |
| unifypharma.com. | MX | 300 | MX Record: 1 aspmx.l.google.com. |
| unifypharma.com. | TXT | 300 | TXT Record: v=spf1 include:mailgun.org ~all |
| unifypharma.com. | TXT | 300 | TXT Record: ahrefs-site-verification_9dea05a8b1ccb67c171303a393a98ada835b5ec11b37af807ff703872947bde7 |
| unifypharma.com. | TXT | 300 | TXT Record: google-site-verification=p71W-bSwxG6uAA6Rx7B-9Bi4cqGK5rKnExIJ-MgqL_Q |
HtmlToTextCheckTime:2022-11-08 10:08:16
| HOME ABOUT US RESEARCH Targets TEAM CONTACT Menu HOME ABOUT US RESEARCH Targets TEAM CONTACT Potent inhibitors of inflammatory and oxidative injury 01 About us Unify is led by some of the brightest scientific minds in the world with a proven record of creating and developing the world’s most successful drugs. Find Out More > Culmination of decades of research Find Out More > 02 Research 03 Targets Targeting a ubiquitous pathological process Find Out More > Leveraging a world-class team Find Out More > 04 Team All Rights Reserved |
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Sun, 17 Apr 2022 08:23:44 GMT
Content-Type: text/html; charset=UTF-8
Connection: keep-alive
X-Redirect-By: WordPress
Vary: Accept-Encoding
Location: https://unifypharma.com/
Cache-Control: max-age=0
Expires: Sun, 17 Apr 2022 08:23:44 GMT
X-Frame-Options: SAMEORIGIN
X-XSS-Protection: 1; mode=block
X-Content-Type-Options: nosniff
CF-Cache-Status: DYNAMIC
Report-To: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=2I%2BPthLJ1vXPbvzguTfi5gHfu8gx1zmJgIEe6RElUnz4NGP3hKpqNAo9BDPEAngz1Vu%2FtDxlBMzJN%2F2yS%2BbRW7DtKVoofExXqk4CQG0j58Wt5aSPqLEsCuZ0gKqSPGkMiWmx3aHqCFXHNxp57oI%3D"}],"group":"cf-nel","max_age":604800}
NEL: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
Server: cloudflare
CF-RAY: 6fd3c2a4de4e1c06-OSL
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
HTTP/2 200
date: Sun, 17 Apr 2022 08:23:45 GMT
content-type: text/html; charset=UTF-8
vary: Accept-Encoding
vary: X-Forwarded-Proto,Accept-Encoding
last-modified: Sun, 17 Apr 2022 06:30:26 GMT
cache-control: max-age=0
expires: Sun, 17 Apr 2022 08:23:45 GMT
x-frame-options: SAMEORIGIN
x-xss-protection: 1; mode=block
x-content-type-options: nosniff
cf-cache-status: DYNAMIC
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=c3J1vpyETbDiDCpSURENdPY0GseQz9xsAGdTO%2F0i3LwINHNetszox5HNlXsLii2ICFY0CaX0BEvFsyrkiugU1aGnXfcOqF1KXdTtp76pQ%2FyoEuMOGrI%2BzkV5%2B0rz7k7NNQIBDhMSrExsRrwPsVA%3D"}],"group":"cf-nel","max_age":604800}
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
cf-ray: 6fd3c2ac1b841c0a-OSL
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400
|
unifypharma.com Whois Information
Domain Name: UNIFYPHARMA.COM Registry Domain ID: 2192144616_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-11-27T11:09:59Z Creation Date: 2017-11-26T18:34:19Z Registry Expiry Date: 2023-11-26T18:34:19Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: DELL.NS.CLOUDFLARE.COM Name Server: LEWIS.NS.CLOUDFLARE.COM DNSSEC: unsigned >>> Last update of whois database: 2022-04-17T08:34:21Z <<< |